Powder: -20°C for 3 years | In solvent: -80°C for 1 year
4-P-PDOT (4-phenyl-2- propionamidotetralin) 是一种选择性和亲和性的褪黑激素受体拮抗剂,可显著抵消褪黑激素介导的抗氧化作用。它对MT2的选择性是 MT1 的 300 倍以上。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 315 | 现货 | ||
5 mg | ¥ 729 | 现货 | ||
10 mg | ¥ 1,150 | 现货 | ||
25 mg | ¥ 2,280 | 现货 | ||
50 mg | ¥ 3,590 | 现货 | ||
100 mg | ¥ 5,180 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 798 | 现货 |
产品描述 | 4-P-PDOT (4-phenyl-2- propionamidotetralin) is a potent, selective and affinity Melatonin receptor (MT2) antagonist. |
体外活性 | In CHO-mt1 cells the amidotetraline 4-P-PDOT (10 mM) has no effect on forskolin-stimulated cyclic AMP levels, either alone, or in the presence of Melatonin. However, in CHO-MT2 cells, 4-P-PDOT is an agonist, producing a concentration-dependent inhibition of forskolin stimulated cyclic AMP, with a pEC50 value of 8.72 and intrinsic activity of 0.86[1]. |
体内活性 | 4-P-PDOT (0.5-1.0 mg/kg; intravenous injection; klotho mutant mice) treatment significantly reverses antioxidant effects mediated by Melatonin. And significantly reverses the changes in the levels of these GSH-related parameters. 4-P-PDOT also counteracts Melatonin-mediated attenuation in response to the decreases in phospho-ERK expression, Nrf2 nuclear translocation, Nrf2 DNA-binding activity, and GCL mRNA expression in the hippocampi of klotho mutant mice[2]. 4-P-PDOT treatment significantly reverses the memory function of Melatonin-treated klotho mutant mice. |
别名 | 4-phenyl-2- propionamidotetralin |
分子量 | 279.38 |
分子式 | C19H21NO |
CAS No. | 134865-74-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 41.67 mg/mL (149.15 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.5794 mL | 17.8968 mL | 35.7935 mL | 89.4839 mL |
5 mM | 0.7159 mL | 3.5794 mL | 7.1587 mL | 17.8968 mL | |
10 mM | 0.3579 mL | 1.7897 mL | 3.5794 mL | 8.9484 mL | |
20 mM | 0.179 mL | 0.8948 mL | 1.7897 mL | 4.4742 mL | |
50 mM | 0.0716 mL | 0.3579 mL | 0.7159 mL | 1.7897 mL | |
100 mM | 0.0358 mL | 0.179 mL | 0.3579 mL | 0.8948 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
4-P-PDOT 134865-74-0 GPCR/G Protein Neuroscience Melatonin Receptor MT Receptor Melatonin 4-phenyl-2- propionamidotetralin GSSG Nrf2 GSH 4PPDOT ERK memory damage Inhibitor oxidative 4 P PDOT MT2 inhibit inhibitor